530: Revisiting the limits of labetalol in the pregnant population: a Trinity Health system analysis
The objective of this study is to compare adverse events in pregnant women who received>300mg IV labetalol versus those who received ≤300mg IV labetalol in a 24-hour period.
Source: American Journal of Obstetrics and Gynecology - Category: OBGYN Authors: Katherine Riddle, Jason Hecht, Caleb Scheidel, Pooja Green, Jennifer Williams Tags: Poster Session II Source Type: research